Related Experiment Video
Updated: Mar 26, 2026
12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
66.3K
Phosphoinositide signalling in type 2 diabetes: a β-cell perspective.
Lucia E Rameh1, Jude T Deeney2
1Department of Medicine, Boston University School of Medicine, 650 Albany Street, Boston, MA 02118, U.S.A. rameh@bu.edu.
Biochemical Society Transactions
|February 11, 2016
Summary
Type 2 diabetes arises from metabolic imbalance, particularly in pancreatic beta-cells. Understanding phosphoinositide roles in beta-cells may reveal new strategies for treating this complex disease.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Diseases
Background:
- Type 2 diabetes results from a failure in energy homeostasis, involving coordinated organ responses regulated by the endocrine pancreas.
- Pancreatic beta-cell dysfunction is a key factor in type 2 diabetes development, influenced by genetic and environmental factors.
- Phosphoinositides act as crucial signal transducers, mediating cellular responses to various environmental cues.
Purpose of the Study:
- To review the established and potential roles of phosphoinositides in pancreatic beta-cell function and dysfunction.
- To explore how phosphoinositide signaling impacts the development of type 2 diabetes.
- To discuss the therapeutic potential of targeting phosphoinositide pathways for type 2 diabetes treatment and prevention.
Main Methods:
- Literature review of phosphoinositide signaling pathways.
- Analysis of genetic association studies related to type 2 diabetes.
- Integration of knowledge on beta-cell physiology and environmental cue decoding by phosphoinositides.
Main Results:
- Genetic variants linked to type 2 diabetes often affect pancreatic beta-cell function.
- Phosphoinositides are implicated in mediating beta-cell responses to hormones, nutrients, and stress.
- Dysregulation of phosphoinositide signaling can contribute to beta-cell dysfunction.
Conclusions:
- The pancreatic beta-cell is a critical 'weak link' in type 2 diabetes pathogenesis.
- Phosphoinositide signaling pathways are vital for maintaining beta-cell function and energy homeostasis.
- Targeting phosphoinositide signaling offers promising avenues for novel type 2 diabetes therapies.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
5.9K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
3.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
3.0K
01:42Phosphoinositides and PIPs
10.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.5K
01:05Insulin Secretory Vesicles
7.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.3K
01:11IP3/DAG Signaling Pathway
15.8K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.8K
01:12What are Second Messengers?
92.6K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
92.6K